Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Oncotarget|February 2, 2017
EZH2 expression is a prognostic biomarker in patients with colorectal cancer treated with anti-EGFR therapeuticsItaru Yamamoto, Katsuhiko Nosho, Shinichi Kanno, et al.
International Journal of Cancer|February 24, 2015
Association of Fusobacterium nucleatum with clinical and molecular features in colorectal serrated pathwayMiki Ito, Shinichi Kanno, Katsuhiko Nosho, et al.
International Journal of Cancer|April 23, 2014
MicroRNA-31 expression in relation to BRAF mutation, CpG island methylation and colorectal continuum in serrated lesionsMiki Ito, Kei Mitsuhashi, Hisayoshi Igarashi, et al.
Digestion|January 31, 2015
Clinicopathological and molecular characteristics of serrated lesions in Japanese elderly patientsKatsuhiko Nosho, Hisayoshi Igarashi, Miki Ito, et al.
World Journal of Gastroenterology|August 12, 2014
IGF2 differentially methylated region hypomethylation in relation to pathological and molecular features of serrated lesionsTakafumi Naito, Katsuhiko Nosho, Miki Ito, et al.
Annals of Surgical Oncology|December 5, 2014
Association of MicroRNA-31-5p with Clinical Efficacy of Anti-EGFR Therapy in Patients with Metastatic Colorectal CancerHisayoshi Igarashi, Hiroyoshi Kurihara, Kei Mitsuhashi, et al.
Oncotarget|March 24, 2015
Association of Fusobacterium species in pancreatic cancer tissues with molecular features and prognosisKei Mitsuhashi, Katsuhiko Nosho, Yasutaka Sukawa, et al.
Carcinogenesis|November 19, 2013
Association of microRNA-31 with BRAF mutation, colorectal cancer survival and serrated pathwayKatsuhiko Nosho, Hisayoshi Igarashi, Masanori Nojima, et al.
Pageof 2